Theseus Pharmaceuticals, Inc.
THRX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $46,893 | $47,465 | $109,698 | $94,605 |
| Short-Term Investments | $158,229 | $160,740 | $126,936 | $103,374 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4,464 | $5,548 | $5,763 | $4,137 |
| Total Curr. Assets | $209,586 | $213,753 | $236,634 | $197,979 |
| Property Plant & Equip (Net) | $4,334 | $4,497 | $4,605 | $4,750 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $20,308 | $26,027 | $6,979 | $13,817 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $399 | $794 | $7,402 | $5,901 |
| Total NC Assets | $25,041 | $31,318 | $18,986 | $24,468 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $234,627 | $245,071 | $255,620 | $222,447 |
| Liabilities | – | – | – | – |
| Payables | $1,313 | $2,415 | $2,185 | $4,973 |
| Short-Term Debt | $759 | $754 | $748 | $743 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $4,582 | $4,164 | $0 | $0 |
| Other Curr. Liab. | $349 | $4,513 | $3,691 | $5,414 |
| Total Curr. Liab. | $7,003 | $7,682 | $6,624 | $11,130 |
| LT Debt | $2,897 | $3,014 | $3,129 | $3,236 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $205 | $292 | $379 | $466 |
| Total NC Liab. | $3,102 | $3,306 | $3,508 | $3,702 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $10,105 | $10,988 | $10,132 | $14,832 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $4 | $4 |
| Retained Earnings | -$155,081 | -$141,577 | -$126,772 | -$112,186 |
| AOCI | -$345 | -$561 | -$159 | -$386 |
| Other Equity | $379,944 | $376,217 | $372,415 | $319,797 |
| Total Equity | $224,522 | $234,083 | $245,488 | $207,615 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $234,627 | $245,071 | $255,620 | $222,447 |
| Net Debt | -$43,237 | -$43,697 | -$105,821 | -$90,626 |